Artemis Wealth Advisors, LLC Amgen Inc Transaction History

Artemis Wealth Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Aug 21, 2023	BUY	$224.46 - $253.15 $673 - $759	3 New	3 $0
Q2 2022 Aug 21, 2023	BUY	$230.71 - $256.74 $692 - $770	3 New	3 $0
Q2 2022 Aug 02, 2022	BUY	$230.71 - $256.74 $692 - $770	3 New	3 $1,000
Q4 2020 Feb 17, 2023	SELL	$216.38 - $257.67 $5,409 - $6,441	-25 Closed	0 $0
Q3 2020 Sep 05, 2023	BUY	$234.65 - $260.95 $5,866 - $6,523	25 New	25 $6,000
Q3 2020 Feb 17, 2023	BUY	$234.65 - $260.95 $5,162 - $5,740	22 Added 733.33%	25 $6,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Artemis Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Artemis Wealth Advisors, LLC with notifications on news.